Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2026 for Arcus Biosciences, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David L. Lacey: trading record in brief
This profile gathers the share dealings of David L. Lacey in Arcus Biosciences, Inc., where the filings describe the role as board member. Between 3 June 2021 and 11 June 2026, the trades on record add up to 6 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 12 June 2026 came the latest disclosure, a share grant in Arcus Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David L. Lacey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
5,700 sharesCommon StockSEC:0001734422-26-000005:0
13,300 shares0Common StockSEC:0001724521-25-000088:0
8,400 shares0Common StockSEC:0001724521-24-000115:0
6,800 shares0Common StockSEC:0001209191-23-038145:0
4,100 shares0Common StockSEC:0001209191-22-037412:0
3,000 shares0Common StockSEC:0001209191-21-038623:0
6 of 6 declarations
